Yikes- let's try that again For newbies…synopsis
The company
New mangement focussed and effective
Enough cash no more dilution in-site
Already scalling up for production and sales
Clearly confident in a Feb FDA go-ahead
The Drug
Endorsed by docs (Urologists)
Safe - in fact it boosts immune response
Effective results - exceed competition
FDA has guided them through app process
FDA set up Advisory Committee review (very positive)
AdCom YES (oncology) Higher rate of approval 100% see link below
BCG the current #1 solution is not reliably available see link
Huge mfg margin
Production facility ready and waiting
The drug is not limited to bladder THINK about that
The drug could easily move to first line therapy
https://seekingalpha.com/author/sujan-lahiri/instablog
https://www.ashp.org/menu/DrugShortages/CurrentShortages/bulletin.aspx?id=915
https://lsconnect.thomsonreuters.com/fda-advisory-committee-votes/